Back to search

Article

What is the potential of Lumacaftor as a chemical chaperone in promoting hERG trafficking?

2024-01-30

Abstract excerpt

Lumacaftor (LUM), approved by the FDA for the treatment of cystic fibrosis(CF), has shown great therapeutic potential in protein conformational diseases. As a chemical chaperone, LUM corrects the F508del CFTR mutation and increases the expression of chloride channels on the alveolar cell membrane. After Mehta et al’s research, the selectivity of LUM has been challenged. In human induced pluripotent stem cell-deriv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4fcd1e54-af81-515a-92b9-85c4488f4308
DOI
10.22541/au.170665535.52632337/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
What is the potential of Lumacaftor as a chemical chaperone in promoting hERG trafficking?DOI 10.22541/au.170665535.52632337/v1
Select a neighboring publication to make it the new centre.